Estudia

• Reconèixer els elements essencials de la professió mèdica, que incloguin els principis ètics, les responsabilitats legals i l'exercici professional centrat en el pacient
• Desenvolupar la pràctica professional amb respecte pels altres professionals de la salut, adquirint habilitats de treball en equip
• Comunicar-se de manera efectiva i clara, tant oralment com per escrit, amb els pacients, els familiars, els mitjans de comunicació i altres professionals
• Conèixer, valorar críticament i saber utilitzar les fonts d'informació clínica i biomèdica per a obtenir, organitzar, interpretar i comunicar la informació científica i sanitària
• Saber utilitzar les tecnologies de la informació i la comunicació en les activitats clíniques, terapèutiques, preventives i d'investigació
• Tenir, en l'activitat professional, un punt de vista crític, creatiu, amb escepticisme constructiu i orientat a la recerca
• Garantir el coneixement adequat de la llengua anglesa, tant oral com escrita, tenint en compte les especificitats del registre mèdic per a poder comunicar-se eficaçment a la comunitat internacional científica i professional

1. Define what “neglected tropical diseases” are and their types, epidemiological situation and transmission

2. Understand differences between control, elimination, eradication of a disease and related with neglected tropical diseases

3. Describe the difference between “mass drug administration” and “case-based” approaches

4. Describe epidemiological indicators needed to monitor and evaluate interventions to control neglected tropical diseases

5. Describe main global challenges for neglected tropical diseases control in different areas (prevention, diagnostics, treatments, implementation and research)

• Sustaining the drive to overcome the global impact of neglected tropical disease. Recuperat , a http://www.who.int/topics/tropical_diseases/en
• Accelerating work to overcome the global impact of neglected tropical diseases. . Recuperat , a http://whqlibdoc.who.int/hq/2012/WHO_HTM_NTD_2012.1_eng.pdf
• PLOS Neglected Tropical Diseases: first open-access journal devoted to the world. Recuperat , a http://www.plosntds.org
• J. Adams. K. Gurney, D. Pendlebury (2012). Thomson Reuters Global Research report neglected tropical diseases.. Dins (Ed.), WHO's Publication. . Recuperat , a http://www.who.int/leishmaniasis/resources/documents/en/PepitoBDFull.pdf
• Hotez PJ, Savioli L, Fenwick A (2012). Neglected Tropical Diseases of the Middle East and North Africa: Review of Their. PLoS Negl Trop Dis , 6(2), 1475. Recuperat , a http://www.plosntds.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjo
• Global Strategy for dengue prevention and control, 2012–2020 (2012). Dins (Ed.), WHO's Publication (, p. 1). WHO.
• Cameron P. S. et al. (2012). Dengue. Current concepts. Review article. N Engl J Med , 366(), 1423-32
• Lang, Jean. (2012). Development of Sanofi Pasteur tetravalent dengue vaccine. Rev. Inst. Med. Trop. Sao Paulo, 54(18), 15-17
• Handbook for clinical management of dengue” WHO and Special Programme for Resear. Recuperat , a http://www.who.int/denguecontrol/9789241504713/en/index.html
• Simarro PP, Diarra A, Ruiz Postigo JA, Franco JR, Jannin JG (2011). The Human African Trypanosomiasis Control and Surveillance Programme of the Worl. PLoS Negl Trop Dis ,,
• Ruiz-Postigo JA, Franco JR, Lado M, Simarro PP (2012). Human African Trypanosomiasis in South Sudan: How Can We Prevent a New Epidemic?. PLoS Negl Trop Dis ,,
• WHO meeting on elimination of human African trypanosomiasis (Trypanosoma brucei . Recuperat , a http://apps.who.int/iris/bitstream/10665/79689/1/WHO_HTM_NTD_IDM_2013.4_eng.pdf
• Simarro PP, Franco J, Diarra A, Postigo JA, Jannin J (2012). Update on field use of the available drugs for the chemotherapy of human African. Parasitology, 139(7), 842
• Mitashi P, Hasker E, Lejon V, Kande V, Muyembe JJ, Lutumba P, Boelaert M (2012). Human african trypanosomiasis diagnosis in first-line health services of endemic. PLoS Negl Trop Dis , 6(11),
• WHO Technical Report Series on the control of the leishmaniases - TRS N°949. Recuperat , a http://apps.who.int/iris/bitstream/10665/44412/1/WHO_TRS_949_eng.pdf
• Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, et al. (2012). Leishmaniasis Worldwide and Global Estimates of Its Incidence. . PloS One, 7(5), 35671
• (2007). Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?. Nature reviews & Microbiology , 5(873),
• Report of the Fifth Consultative Meeting on Leishmania/HIV Coinfection. Addis Ab. Recuperat , a http://www.who.int/leishmaniasis/resources/Leishmaniasis_hiv_coinfection5.pdf
• Bern C, Courtenay O, Alvar J (2010). Of Cattle, Sand Flies and Men: A Systematic Review of Risk Factor Analyses for S. PLoS Negl Trop Dis , 4(2), 599
• Stauch A, Sarkar RR, Picado A, Ostyn B, Sundar S, Rijal S, Boelaert M, Dujardin (2011). Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and co. PLoS Negl Trop Dis , 5(11),
• Pepito y la leishmaniasis. (1999). . Recuperat , a http://www.who.int/leishmaniasis/resources/documents/en/PepitoBDFull.pdf

Activitats d'avaluació:

Evaluation has two parts (PBL sessions and PBL exam) and both of them must be passed independently. In case PBL exam is failed, there will be a second opportunity to do it, but with a maximum score of 5 points.

- PBL sessions evaluation will account for 50% of the module evaluation.
Criteria (Grade proportion)
Responsibility (25%)
Learning abilities (25%)
Communication (25%)
Interpersonal
relationships (25%)

- The PBL exam is going to account for the other 50%.

1st Part (20%)

Justification

2nd Part (70%)

Accreditation of knowledge acquired within the question context

Both Parts (10%)

Readability and conciseness

More than 1 billion people – a sixth of the world’s population – suffer from one or more neglected tropical diseases. These diseases represent about 17% of the global burden of parasitic and infectious diseases.

Most neglected tropical diseases are endemic in rural areas of sub-Saharan Africa and in poor urban settings of low-income countries in Asia and Latin America. They lead to long-term disability, disfigurement, impaired childhood growth, adverse pregnancy outcomes and reduced economic productivity.

Neglected tropical diseases kill an estimated 534.000 people worldwide every year. Their impact on worker productivity adds up to billions of dollars lost annually and maintains low-income countries in poverty.

Addressing neglected tropical diseases from a public health perspective often involve negotiations not only on what we want (our interests), but also on core beliefs about public health needs and priorities, and the way government and society should be working to respond to those needs and priorities (our values). Negotiations involving value conflicts are often more challenging to resolve than negotiations based primarily on interests, because negotiators may be reluctant to trade off their principles for the sake of their interests.

This elective provides the opportunity to learn the current global situation of neglected tropical diseases, how large-scale interventions for control are organized and main challenges for implementation and sustainability of control.